Literature DB >> 12554654

The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Josiane Ragimbeau1, Elisabetta Dondi, Andrés Alcover, Pierre Eid, Gilles Uzé, Sandra Pellegrini.   

Abstract

The four mammalian Jak tyrosine kinases are non-covalently associated with cell surface receptors binding helical bundled cytokines. In the type I interferon receptor, Tyk2 associates with the IFNAR1 receptor subunit and positively influences ligand binding to the receptor complex. Here, we report that Tyk2 is essential for stable cell surface expression of IFNAR1. In the absence of Tyk2, mature IFNAR1 is weakly expressed on the cell surface. Rather, it is localized into a perinuclear endosomal compartment which overlaps with that of recycling transferrin receptors and with early endosomal antigen-1 (EEA1) positive vesicles. Conversely, co-expressed Tyk2 greatly enhances surface IFNAR1 expression. Importantly, we demonstrate that Tyk2 slows down IFNAR1 degradation and that this is due, at least in part, to inhibition of IFNAR1 endocytosis. In addition, Tyk2 induces plasma membrane relocalization of the R2 subunit of the interleukin-10 receptor. These results reveal a novel function of a Jak protein on internalization of a correctly processed cytokine receptor. This function is distinct from the previously reported effect of other Jak proteins on receptor exit from the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554654      PMCID: PMC140723          DOI: 10.1093/emboj/cdg038

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

Review 1.  The function of type I interferons in antimicrobial immunity.

Authors:  C Bogdan
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

2.  A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.

Authors:  T C Yeh; E Dondi; G Uze; S Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.

Authors:  A Takaoka; Y Mitani; H Suemori; M Sato; T Yokochi; S Noguchi; N Tanaka; T Taniguchi
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

Review 4.  Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes.

Authors:  S V Kotenko; S Pestka
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor.

Authors:  S Thiel; I Behrmann; A Timmermann; H Dahmen; G Müller-Newen; F Schaper; J Tavernier; V Pitard; P C Heinrich; L Graeve
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

6.  A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation.

Authors:  L Supino-Rosin; A Yoshimura; H Altaratz; D Neumann
Journal:  Eur J Biochem       Date:  1999-07

7.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.

Authors:  K Shimoda; K Kato; K Aoki; T Matsuda; A Miyamoto; M Shibamori; M Yamashita; A Numata; K Takase; S Kobayashi; S Shibata; Y Asano; H Gondo; K Sekiguchi; K Nakayama; T Nakayama; T Okamura; S Okamura; Y Niho; K Nakayama
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

9.  Partial impairment of cytokine responses in Tyk2-deficient mice.

Authors:  M Karaghiosoff; H Neubauer; C Lassnig; P Kovarik; H Schindler; H Pircher; B McCoy; C Bogdan; T Decker; G Brem; K Pfeffer; M Müller
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

10.  Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs.

Authors:  R Gongora; R P Stephan; R D Schreiber; M D Cooper
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

View more
  79 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases.

Authors:  Jin-Hui Tao; Yan-Feng Zou; Xiao-Liang Feng; Jing Li; Fang Wang; Fan-Ming Pan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

3.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

4.  Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Authors:  Rebecca A R Piganis; Nicole A De Weerd; Jodee A Gould; Christian W Schindler; Ashley Mansell; Sandra E Nicholson; Paul J Hertzog
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

5.  Ligand-independent pathway that controls stability of interferon alpha receptor.

Authors:  Jianghuai Liu; Alexander Plotnikov; Anamika Banerjee; K G Suresh Kumar; Josiane Ragimbeau; Zrinka Marijanovic; Darren P Baker; Sandra Pellegrini; Serge Y Fuchs
Journal:  Biochem Biophys Res Commun       Date:  2007-12-31       Impact factor: 3.575

Review 6.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

7.  Jun activation domain-binding protein 1 (JAB1) is required for the optimal response to interferons.

Authors:  Ryuta Muromoto; Maiko Nakajima; Koki Hirashima; Toru Hirao; Shigeyuki Kon; Kazuya Shimoda; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 8.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

Review 9.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

10.  The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Authors:  K M Shah; S E Stewart; W Wei; C B J Woodman; J D O'Neil; C W Dawson; L S Young
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.